Safety and Efficacy of Cryoablation in the Treatment of Advanced Bone and Soft Tissue Tumors: a Single-center Retrospective Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Survival rates
研究概览
简要总结
This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. All eligible patients were enrolled. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
详细描述
This is a single-center, open, retrospective clinical study of patients with metastatic/surgically unresectable bone and soft tissue sarcoma undergoing cryoablation of selected tumor lesions. Clinical data of eligible patients were scheduled to be retrospectively collected from December 2016 to February 28, 2022. All patients eligible for inclusion. Basic data and treatment methods of these patients were collected, and efficacy and safety were evaluated.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •No age restriction, male or female.
- •The pathological diagnosis was a subtype of bone and soft tissue sarcoma.
- •The clinical stage was determined to be metastatic or locally unresectable bone and soft tissue sarcoma.
- •At least one cryoablation of tumor lesions was performed in our hospital.
- •Target lesions can be evaluated according to the efficacy evaluation criteria for solid tumors (RECIST; Version 1.1) Measure diameter changes.
- •Follow-up data were complete.
排除标准
- •Not applicable.
结局指标
主要结局
Survival rates
时间窗: 12 months after surgery
1-year survival rate
There was no local recurrence survival rate
时间窗: 12 months after surgery
The 1-year survival rate without local recurrence
次要结局
未报告次要终点
研究者
Wang Jiaqiang
associate chief physician
Henan Cancer Hospital